Skip to content

GFATM

The Global Fund to Fight AIDS, Tuberculosis and Malaria.

Objectives

The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), established in 2002, is a public-private partnership and international financing institution. GFATM invests funds in countries to support large-scale prevention, treatment and care programs against HIV/AIDS (50%), tuberculosis (18%) and malaria (32%). Under the current allocation model more than 90 percent of investments were delivered to low- and lower-middle-income countries, and more than 95 percent to high-burden countries.

The role of the Fund
GFATM is uniquely placed in the multilateral system and has contributed immensely to the achievement of the Millennium Development Goals (MDGs) as the biggest financial contributor, in particular to MDG6. The fund's first decade has been characterized by rapid growth, notable successes and mobilization of billions of US dollars to fight HIV/AIDS, tuberculosis and malaria. As of September 2015 the Fund had disbursed 27 billion USD to combat the three diseases since its initiation.

As of end-2015programmes supported by GFATM have contributed to;
-saving more than 17 million lives;
-getting 8.6 million people on antiretroviral treatment for HIV;
-treating 15 million people for TB;
-and distributing 600 million bed nets for Malaria protection.

At its board meeting in Abidjan in April 2016, the Global Fund to Fight HIV / AIDS, TB and Malaria (GFATM) adopted a new strategy for the Fund (2017-22), supplemented by a number of key supporting policies that will help the Fund target its efforts where there is the biggest need and they will have the biggest impact. The strategy and policies further prioritise poverty reduction, gender equality and human rights, as well as strengthening of health systems. The well advanced strategic monitoring framework (Key Performance Indicators 2017-2022), was discussed at the Board meeting and is expected to be adopted in the near future. This comprehensive package will ensure that the Fund is "Fit for Purpose", adapted to the new overall political agenda, including the 2030 agenda and the SDGs, better equipped to make impact and thus, ready for its 5th replenishment.

Denmark’s cooperation with the Global Fund
Denmark’s cooperation with the Global Fund is based on the Danish Organisation Strategy for the Global Fund to fight AIDS, Tuberculosis and Malaria, 2014-2017. The Global Fund is a key partner for Denmark in poverty reduction, achievement of social progress and fulfilment of the SDGs. The explicit focus on promotion and prevention of human rights in the Funds’ strategic framework makes the Fund an important partner for Denmark in implementing the human rights-based approach in the development cooperation.

Denmark’s four priorities for the cooperation are; institutional reform processes; sustaining efforts to fight corruption through rigorous risk management; ensuring that the human rights-based approach (participation, inclusion, transparency, accountability) permeates all actions; and maximising GFATM impact on strengthening health systems. Denmark is part of the Point Seven constituency (Norway, Ireland, Luxembourg, Netherlands, and Sweden) where Denmark serves as Board member for a two-year period that commenced on April 2015.

Read the Danish Organisation Strategy for the Global Fund to fight AIDS, Tuberculosis and Malaria, 2014-2017

 

Updated 12/05/2016

About GFATM

Executive Director 
Mark Dybul  (US)
since November 2012


The Global Fund Board
27 members 


Denmark’s core contribution in 2015 
DKK 100 million (from development assistance)